STANDARD BIOTOOLS INC. — Director's Dealing 2021

Nov 25, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2021-11-20

Reporting Person: Linthwaite Stephen Christopher (President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-20	Common Stock	M	7813	—	Acquired	311907	Direct
2021-11-20	Common Stock	M	6882	—	Acquired	318789	Direct
2021-11-20	Common Stock	M	7722	—	Acquired	326511	Direct
2021-11-20	Common Stock	F	11287	$4.49	Disposed	315224	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-20	Restricted Stock Units	$	M	7813	Disposed		Common Stock (7813.0)	Direct
2021-11-20	Restricted Stock Units	$	M	6882	Disposed		Common Stock (6882.0)	Direct
2021-11-20	Restricted Stock Units	$	M	7722	Disposed		Common Stock (7722.0)	Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F2: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter.

F3: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F4: On March 10, 2020, the Reporting Person was granted 123,555 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.